Loading...
•
Dec 31, 2019
ICU Medical Q4 2019 Earnings Report
ICU Medical's fourth quarter results reflected a decrease in revenue compared to the same period last year, but net income improved significantly.
Key Takeaways
ICU Medical reported a revenue of $315.5 million for Q4 2019, a decrease from $340.4 million in Q4 2018. However, the company's net income increased to $20.6 million, or $0.96 per diluted share, compared to a net loss of $7.4 million, or $0.36 loss per diluted share, in the same period last year. Adjusted diluted earnings per share were $1.94, and adjusted EBITDA was $60.7 million.
Q4 2019 revenue was $315.5 million, down from $340.4 million year-over-year.
GAAP net income was $20.6 million, or $0.96 per diluted share, compared to a net loss of $7.4 million, or $0.36 loss per diluted share, in Q4 2018.
Adjusted diluted earnings per share were $1.94, compared to $2.14 in the same period last year.
Adjusted EBITDA was $60.7 million, compared to $69.3 million in the prior year.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Revenue by Segment
Consumables Revenue
CapyFin.comInfusion Systems Revenue
CapyFin.com Forward Guidance
For the Fiscal Year 2020, the Company expects adjusted EBITDA to be in the range of $240 million to $260 million, and adjusted diluted EPS to be in the range of $6.50 to $7.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income